Component

Mouse POU class 2 homeobox 2 / Pou2f2

Mouse POU class 2 homeobox 2 / Pou2f2. Species, exposure and limitations are retained in each linked claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. POU2F2 promoted osteoclastogenesis through c-Fos induction.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/nasunin-research/41407214.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08", "start_char": 0, "end_char": 1949, "text_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08"}
    experimental_model
    Mouse transfer/ablation experiments, cell assays and virtual screening
    exposure
    Nasunin intervention reported; exact regimen and binding validation unavailable in the indexed abstract
    limitations
    New preclinical study: virtual screening nomination is not a measured binding affinity. The pathway findings and treatment outcomes are retained separately. No human efficacy or dose inference.
    nutrient_topic
    Nasunin research collection; topical membership is not evidence of a direct dietary effect. · Nasunin
    organism
    Type 2 diabetic and control mice; mouse primary-cell models
    plain_language
    The chain reaches a regulator of bone-resorbing cell formation.
    primary_references
    [nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139
    tissue_or_cell_type
    Neutrophil-to-macrophage signaling and osteoclastogenesis

    Nasunin: identity, redox chemistry and nutrient connections (2026-09-17) · lines 458–469

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mouse transfer/ablation experiments, cell assays and virtual screening · source_derived_draft · unverified_draft

    ### nasunin-pou2f2-fos POU2F2 promoted osteoclastogenesis through c-Fos induction. Condition category: normal nutrient_topic: Nasunin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The chain reaches a regulator of bone-resorbing cell formation. organism: Type 2 diabetic and control mice; mouse primary-cell models tissue_or_cell_type: Neutrophil-to-macrophage signaling and osteoclastogenesis experimental_model: Mouse transfer/ablation experiments, cell assays and virtual screening limitations: New preclinical study: virtual screening nomination is not a measured binding affinity. The pathway findings and treatment outcomes are retained separately. No human efficacy or dose inference. exposure: Nasunin intervention reported; exact regimen and binding validation unavailable in the indexed abstract evidence_span: {"source_cache": "artifacts/nasunin-research/41407214.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08", "start_char": 0, "end_char": 1949, "text_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08"} [nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139
    Complete structured claim and evidence

What acts on it

  1. PPARgamma increased POU2F2 transcription.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/nasunin-research/41407214.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08", "start_char": 0, "end_char": 1949, "text_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08"}
    experimental_model
    Mouse transfer/ablation experiments, cell assays and virtual screening
    exposure
    Nasunin intervention reported; exact regimen and binding validation unavailable in the indexed abstract
    limitations
    New preclinical study: virtual screening nomination is not a measured binding affinity. The pathway findings and treatment outcomes are retained separately. No human efficacy or dose inference.
    nutrient_topic
    Nasunin research collection; topical membership is not evidence of a direct dietary effect. · Nasunin
    organism
    Type 2 diabetic and control mice; mouse primary-cell models
    plain_language
    A second regulator links the upstream signal to cell differentiation.
    primary_references
    [nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139
    tissue_or_cell_type
    Neutrophil-to-macrophage signaling and osteoclastogenesis

    Nasunin: identity, redox chemistry and nutrient connections (2026-09-17) · lines 445–456

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mouse transfer/ablation experiments, cell assays and virtual screening · source_derived_draft · unverified_draft

    ### nasunin-pparg-pou2f2 PPARgamma increased POU2F2 transcription. Condition category: normal nutrient_topic: Nasunin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A second regulator links the upstream signal to cell differentiation. organism: Type 2 diabetic and control mice; mouse primary-cell models tissue_or_cell_type: Neutrophil-to-macrophage signaling and osteoclastogenesis experimental_model: Mouse transfer/ablation experiments, cell assays and virtual screening limitations: New preclinical study: virtual screening nomination is not a measured binding affinity. The pathway findings and treatment outcomes are retained separately. No human efficacy or dose inference. exposure: Nasunin intervention reported; exact regimen and binding validation unavailable in the indexed abstract evidence_span: {"source_cache": "artifacts/nasunin-research/41407214.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08", "start_char": 0, "end_char": 1949, "text_sha256": "e0958157d5bc8c5df908b6d7ff18348c83726b06b63d2dc6953ebfd2ffdf0a08"} [nasunin-p41407214] Neutrophil-derived thrombospondin-1 (THBS1) drives type 2 diabetes-induced osteoporosis via CD36-PPARγ-POU2F2 signaling. (2026). https://pubmed.ncbi.nlm.nih.gov/41407214/ DOI: 10.1016/j.bbadis.2025.168139
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards